ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 16.8431 ↑ 0.08%
[as on 16 April, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option and its peers as on 16 April, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option -0.98% 0.08% 2.27% 3.48% 0.97% 0.45% 20.92%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -6.21% 0.23% 2.96% 6.17% -3.29% -4.48% 13.16% 16.63% 14.4% 15.43%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -5.02% 0.08% 3.13% 6.12% -3.82% 5.92% 13.93% 12.41% 12.82% 13.08%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 1.86% 1.28% 2.53% 2.55% 1.83% 5.57% 25.51% 17.28% 20.91% 13.17%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -1.57% 0.94% 4.65% 7.45% 1.22% 5% 21.17% 21.42% 18.71% 16.53%
SBI PSU Fund - DIRECT PLAN - GROWTH 5.73% 0.4% 3.11% 4.85% 5.15% 19.87% 34.32% 29.23% 20.39% 16.68%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns------ -6.9% 35.22% 44.46% -9.08%

Discrete returns (monthly)

MonthJun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026
Returns 3.38% 2.48% -1.75% -1.48% 2.29% -1.03% -2.44% -6.81% 6.98% -4.59%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns -4%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.96%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.97%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.35%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.71%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.51%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology4.43%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.98%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.70%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.62%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.07%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.04%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.95%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology2.82%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology2.57%
Wockhardt LimitedWOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology2.27%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.20%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.77%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.73%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology1.69%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.53%
FDC LimitedFDC (INE258B01022)Pharmaceuticals & Biotechnology1.40%
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals1.35%
SBI Life Insurance Company LimitedSBILIFE (INE123W01016)Insurance1.25%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.23%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.22%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.21%
Onesource Specialty Pharma LimitedONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology1.19%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.19%
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology1.13%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.13%
Standard Glass Lining Technology LtdSGLTL (INE0M4D01010)Industrial Manufacturing1.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.99%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies0.93%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.86%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.85%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.81%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.75%
UPL LimitedUPL (INE628A01036)Fertilizers & Agrochemicals0.72%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.70%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.48%

Debt

NameRatingWeight %
Portfolio data is as on date 31 October, 2025

NAV history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
16 April, 202616.8431 0.08%
15 April, 202616.8291 1.69%
13 April, 202616.5493 -0.49%
10 April, 202616.6308 0.98%
9 April, 202616.4693 0.71%
8 April, 202616.3538 1.28%
7 April, 202616.1477 0.14%
6 April, 202616.1245 0.45%
2 April, 202616.0525 -0.74%
1 April, 202616.1715 0.5%
31 March, 202616.0904 0%
30 March, 202616.0906 -1.51%
27 March, 202616.3375 -0.79%
25 March, 202616.4669 1.61%
24 March, 202616.2061 1.6%
23 March, 202615.9504 -2.27%
20 March, 202616.3204 1.44%
19 March, 202616.0881 -2.4%
18 March, 202616.4836 0.48%
17 March, 202616.4053 0.79%
16 March, 202616.2770 -1.08%
13 March, 202616.4545 -2.01%
12 March, 202616.7912 -0.65%
11 March, 202616.9003 0.2%
10 March, 202616.8673 -0.65%
9 March, 202616.9784 -0.18%
6 March, 202617.0090 0.26%
5 March, 202616.9651 0.69%
4 March, 202616.8496 -1.46%
2 March, 202617.0991

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 16.8431 as on 16 April, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -0.98% as on 16 April, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 0.45% as on 16 April, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 20.92% as on 16 April, 2026.